DIMETANE-DX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dimetane-dx, and what generic alternatives are available?
Dimetane-dx is a drug marketed by Robins Ah and is included in one NDA.
The generic ingredient in DIMETANE-DX is brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride. There are twenty-one drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIMETANE-DX?
- What are the global sales for DIMETANE-DX?
- What is Average Wholesale Price for DIMETANE-DX?
Summary for DIMETANE-DX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | DIMETANE-DX at DailyMed |
US Patents and Regulatory Information for DIMETANE-DX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Robins Ah | DIMETANE-DX | brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride | SYRUP;ORAL | 019279-001 | Aug 24, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |